{"id":"https://openalex.org/W7140308446","doi":"https://doi.org/10.2139/ssrn.6460521","title":"Higher serum activin A predicts adverse outcomes in AI-refractory hormone receptor-positive metastatic breast cancer in the Phase III BOLERO-2 trial (everolimus + exemestane vs exemestane alone)","display_name":"Higher serum activin A predicts adverse outcomes in AI-refractory hormone receptor-positive metastatic breast cancer in the Phase III BOLERO-2 trial (everolimus + exemestane vs exemestane alone)","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7140308446","doi":"https://doi.org/10.2139/ssrn.6460521"},"language":"en","primary_location":{"id":"doi:10.2139/ssrn.6460521","doi":"https://doi.org/10.2139/ssrn.6460521","is_oa":true,"landing_page_url":"https://doi.org/10.2139/ssrn.6460521","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"preprint","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.2139/ssrn.6460521","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075336038","display_name":"Laura K. Krecko","orcid":"https://orcid.org/0000-0002-5516-0664","observed_orcids":["https://orcid.org/0000-0002-5516-0664"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura  K. Krecko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130605467","display_name":"Ayesha Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799360765","display_name":"Thomas Jefferson University Hospital","ror":"https://ror.org/04zhhva53","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799360765","https://openalex.org/I4210114575"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayesha Ali","raw_affiliation_strings":["Thomas Jefferson University Hospital","Thomas Jefferson University Hospital, 111 South 11th Street, Philadelphia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomas Jefferson University Hospital","institution_ids":["https://openalex.org/I2799360765"]},{"raw_affiliation_string":"Thomas Jefferson University Hospital, 111 South 11th Street, Philadelphia, PA, United States","institution_ids":["https://openalex.org/I2799360765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048870477","display_name":"Meghan M. Hupp","orcid":"https://orcid.org/0000-0002-2861-7585","observed_orcids":["https://orcid.org/0000-0002-2861-7585"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meghan Hupp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109645345","display_name":"Ashley Kang","orcid":"https://orcid.org/0009-0009-3670-8434","observed_orcids":["https://orcid.org/0009-0009-3670-8434"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashley Kang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073972374","display_name":"Hyma Vani Polimera","orcid":"https://orcid.org/0000-0001-5800-2111","observed_orcids":["https://orcid.org/0000-0001-5800-2111"]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hyma Vani Polimera","raw_affiliation_strings":["Pennsylvania State University - Penn State Hershey Medical Center","Pennsylvania State University - Penn State Hershey Medical Center, 500 University Dr, Hershey, PA 17033, United States"],"raw_orcid":"https://orcid.org/0000-0001-5800-2111","affiliations":[{"raw_affiliation_string":"Pennsylvania State University - Penn State Hershey Medical Center","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Pennsylvania State University - Penn State Hershey Medical Center, 500 University Dr, Hershey, PA 17033, United States","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031275594","display_name":"Suhail M. Ali","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suhail  M. Ali","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044542632","display_name":"Kim Leitzel","orcid":"https://orcid.org/0000-0003-2328-6083","observed_orcids":["https://orcid.org/0000-0003-2328-6083"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kim Leitzel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042639983","display_name":"Eric I Marks","orcid":"https://orcid.org/0000-0002-7937-0199","observed_orcids":["https://orcid.org/0000-0002-7937-0199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Marks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130561348","display_name":"Albert Reisling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Albert Reisling","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation","Novartis Pharmaceuticals Corporation, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, United States","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001796461","display_name":"Scott J. Hofsess","orcid":"https://orcid.org/0000-0002-8465-4065","observed_orcids":["https://orcid.org/0000-0002-8465-4065"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Hofsess","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation","Novartis Pharmaceuticals Corporation, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, United States","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070183880","display_name":"Robert Sweetman","orcid":"https://orcid.org/0000-0002-8165-4262","observed_orcids":["https://orcid.org/0000-0002-8165-4262"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Sweetman","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation","Novartis Pharmaceuticals Corporation, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, United States","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130595630","display_name":"Steve Nowmos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steve Nowmos","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation","Novartis Pharmaceuticals Corporation, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, United States","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000466713","display_name":"Daniel Rooks","orcid":"https://orcid.org/0000-0002-1121-3517","observed_orcids":["https://orcid.org/0000-0002-1121-3517"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel  S. Rooks","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation","Novartis Pharmaceuticals Corporation, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I4210117619"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, United States","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110128500","display_name":"Cristina I. Truica","orcid":"https://orcid.org/0000-0002-8462-5678","observed_orcids":["https://orcid.org/0000-0002-8462-5678"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristina Truica","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078770803","display_name":"Monali K. Vasekar","orcid":"https://orcid.org/0000-0003-2369-8133","observed_orcids":["https://orcid.org/0000-0003-2369-8133"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monali Vasekar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006374017","display_name":"Vinod Nagabhairu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vinod Nagabhairu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050776933","display_name":"Angelique Ellerbee Richardson","orcid":"https://orcid.org/0000-0002-8944-0066","observed_orcids":["https://orcid.org/0000-0002-8944-0066"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angelique Richardson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8944-0066","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028704827","display_name":"Ashok Maddukuri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashok Maddukuri","raw_affiliation_strings":["Pennsylvania State University - Penn State Hershey Medical Center","Pennsylvania State University - Penn State Hershey Medical Center, 500 University Dr, Hershey, PA 17033, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pennsylvania State University - Penn State Hershey Medical Center","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Pennsylvania State University - Penn State Hershey Medical Center, 500 University Dr, Hershey, PA 17033, United States","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077734346","display_name":"Prashanth Reddy Moku","orcid":"https://orcid.org/0000-0002-7216-9847","observed_orcids":["https://orcid.org/0000-0002-7216-9847"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prashanth Moku","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130573195","display_name":"Karen Muindi","orcid":"https://orcid.org/0009-0006-4396-3319","observed_orcids":["https://orcid.org/0009-0006-4396-3319"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Muindi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-4396-3319","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130552043","display_name":"Maren May","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maren May","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018617106","display_name":"Gabriel N. Hortob\u00e1gyi","orcid":"https://orcid.org/0000-0002-4873-4412","observed_orcids":["https://orcid.org/0000-0002-4873-4412"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriel Hortobagyi","raw_affiliation_strings":["University of Texas at Houston - MD Anderson Cancer Center","University of Texas at Houston - MD Anderson Cancer Center, Unit 1905, Houston, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas at Houston - MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Texas at Houston - MD Anderson Cancer Center, Unit 1905, Houston, TX, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jose Baselga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060255577","display_name":"A. Lipton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Lipton","raw_affiliation_strings":["Pennsylvania State University - Penn State Hershey Medical Center","Pennsylvania State University - Penn State Hershey Medical Center, 500 University Dr, Hershey, PA 17033, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pennsylvania State University - Penn State Hershey Medical Center","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]},{"raw_affiliation_string":"Pennsylvania State University - Penn State Hershey Medical Center, 500 University Dr, Hershey, PA 17033, United States","institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5073972374"],"corresponding_institution_ids":["https://openalex.org/I130769515","https://openalex.org/I82783531"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.01899999938905239,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/activin-a","display_name":"activin A","score":0.9760000109672546},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.7689999938011169},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.8809999823570251},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.8619999885559082},{"id":"https://openalex.org/keywords/exemestane","display_name":"exemestane","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bolero-2-trial","display_name":"BOLERO-2 trial","score":0.9359999895095825},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8080000281333923},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9470000267028809},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.5910000205039978},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9154000282287598},{"id":"https://openalex.org/C2775860665","wikidata":"https://www.wikidata.org/wiki/Q418819","display_name":"Exemestane","level":5,"score":0.9036999940872192},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7347000241279602},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6320000290870667},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5658000111579895},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5113000273704529},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4049000144004822},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36079999804496765},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3463999927043915},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3425999879837036},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.32440000772476196},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.30399999022483826},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.3028999865055084},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.30239999294281006},{"id":"https://openalex.org/C2778831791","wikidata":"https://www.wikidata.org/wiki/Q408122","display_name":"Follistatin","level":2,"score":0.2928999960422516},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.2915000021457672},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2892000079154968},{"id":"https://openalex.org/C2778504769","wikidata":"https://www.wikidata.org/wiki/Q3040305","display_name":"Aromatase inhibitor","level":5,"score":0.2849000096321106},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.2784000039100647},{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.2732999920845032},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.26089999079704285},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.25519999861717224}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2139/ssrn.6460521","doi":"https://doi.org/10.2139/ssrn.6460521","is_oa":true,"landing_page_url":"https://doi.org/10.2139/ssrn.6460521","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.2139/ssrn.6460521","doi":"https://doi.org/10.2139/ssrn.6460521","is_oa":true,"landing_page_url":"https://doi.org/10.2139/ssrn.6460521","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2792412273","https://openalex.org/W2221786451","https://openalex.org/W2032390346","https://openalex.org/W2329974958","https://openalex.org/W2335170849","https://openalex.org/W2127758887","https://openalex.org/W2140406690","https://openalex.org/W2222576582","https://openalex.org/W2125047786","https://openalex.org/W2184290939"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-03-26T00:00:00"}